Inventiva SA IVA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
3.40quote price arrow down-0.05 (-1.45%)
Volume
1,374
52 week range
2.46 - 5.05
Loading...
  • Open3.41
  • Day High3.44
  • Day Low3.41
  • Prev Close3.45
  • 52 Week High5.05
  • 52 Week High Date06/16/23
  • 52 Week Low2.46
  • 52 Week Low Date05/17/23

Key Stats

  • Market Cap171.98M
  • Shares Out52.12M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1
  • YTD % Change-23.83

KEY STATS

  • Open3.41
  • Day High3.44
  • Day Low3.41
  • Prev Close3.45
  • 52 Week High5.05
  • 52 Week High Date06/16/23
  • 52 Week Low2.46
  • 52 Week Low Date05/17/23
  • Market Cap171.98M
  • Shares Out52.12M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1
  • YTD % Change-23.83

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inventiva SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various...
Frederic Cren
Chairman of the Board, Chief Executive Officer, Co-Founder, Member of the Executive Committee
Jean Volatier
Chief Financial Officer, Chief Administrative Officer, Member of the Executive Committee
Address
50 rue de Dijon, Daix
Daix
21121
France